Direktorat Registrasi ObatValid

ABILIFY MAINTENA

Claim this product
BPOM Number
DKI1756101925B1
Approved
21 November 2024
Expiry
13 November 2027
Form
SUSPENSI INJEKSI PELEPASAN LAMBAT; 400 MG

About This Registration

ABILIFY MAINTENA is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI1756101925B1. Its current registration status is Valid, with the licence valid until 13 November 2027. The product is registered to OTSUKA INDONESIA - INDONESIA. BPOM first approved this registration in November 2022. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 1 PREFILLED DUAL CHAMBER SYRINGE
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Ingredients (1)

ARIPIPRAZOLE

Market Intelligence

Owner Portfolio
OTSUKA INDONESIA - INDONESIA holds 113 BPOM registrations
Manufacturer Scale
OTSUKA INDONESIA - INDONESIA produces 113 registered products
Registration Age
Registered for 3 years, 10 months

FDA Cross-Reference

via openFDA
Generic Name
ARIPIPRAZOLE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1